chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.5
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Drug toxicity, Drug withdrawal syndrome, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning an 18 month old male who on 1/7/97 was vaccinated with a dose of hep B vaccine (lot 619303/1282D, reported). Concomitant therapy included doses 1, 2, 3, and 4 of Tetramune vacicne (429-972) administered on 11/29/95 and 2/2/96 (432-656) administered on 4/22/96 (444-257) administered on 5/5/97; HIB conjugate vaccine (M270PA) administered on 5/5/97; doses 1 and 2 of hep B vaccine (1817A2) administered on 11/29/95 and (1943A2) administered on 2/2/96; and pneumococcal vaccine 23 polyvalent (441/213) administered on 10/20/97. It is alleged that through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via and IM injection of mercury, the pt suffered devastating, permanent, neurologically devastated by the accumulation of mercury in his body, having been exposed via IM injections and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engag in in repetitive behavior and the loss of language skills, motor skills and affect. Upon internal review, merucry toxicity and neurological disorders were considered to be other important medical events. No further info is available.
Age: 1.5
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: Information has been received regarding a case in litigation concerning an 18 month old male who on 1/7/97 was vaccinated with a dose of hep B vaccine (lot 619303/1282D, reported). Concomitant therapy included doses 1, 2, 3, and 4 of Tetramune vacicne (429-972) administered on 11/29/95 and 2/2/96 (432-656) administered on 4/22/96 (444-257) administered on 5/5/97; HIB conjugate vaccine (M270PA) administered on 5/5/97; doses 1 and 2 of hep B vaccine (1817A2) administered on 11/29/95 and (1943A2) administered on 2/2/96; and pneumococcal vaccine 23 polyvalent (441/213) administered on 10/20/97. It is alleged that through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via and IM injection of mercury, the pt suffered devastating, permanent, neurologically devastated by the accumulation of mercury in his body, having been exposed via IM injections and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engag in in repetitive behavior and the loss of language skills, motor skills and affect. Upon internal review, merucry toxicity and neurological disorders were considered to be other important medical events. No further info is available.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Convulsion, Heart rate increased, Hypertension, Respiratory rate increased, Tremor
Clinical narrative: Rec'd vaccine Sunday @ 11:30AM, Reaction Tuesday @ 19:30, Arms started trembling,increased temperature,BP, HR,RR, Notified MD, 911 called , taken to hospital, Seizure continus, Rectal temp at hosp - 104.6@ 9:45PM. Motrin liquid & Tylenol suppository given, X-ray,cultures done - all neg
Age: 1.3
Sex: F
Vaccine: HIBV, MMR, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Seizure on 11/01/02, lasted 1 hour, intubated, Flown to Level III hospital. follow up report received 11/25/02 states  "Fever"
Age: 1.09
Sex: M
Vaccine: MMR
Symptoms: Deafness, Hearing impaired, Pyrexia, Rash
Clinical narrative: 60 day follow up information states deafness - moderate, severe loss, and PDD. The annual follow up received on 12/5/03 states pt has a moderate/severe sensorineural hearing loss.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Convulsion, Eye movement disorder, Pyrexia, Tremor, Vomiting
Clinical narrative: Patient woke from a nap. Took usual feeding, then vomited. Mom laid patient on his back and he ?, shaking, eyes rolled back; lasted for 10-20 seconds. Vomited some juice about 1 hour later, but had no recurrence. Hospitalized for observation; no recurrence. The discharge summary states low grade fever. Also, the diagnosis is stated as "Possible seizure post vaccination with vaccination reaction."
Age: 47.0
Sex: M
Vaccine: UNK
Symptoms: Injection site pain, Myalgia
Clinical narrative: Soreness around vaccinated area, next day and following- muscle ache under left arm pit area radiating to left chest muscle area. 21 Nov 02 area still sore not as bad, but still noticable
Age: 17.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Bradycardia, Hypertension
Clinical narrative: Patient go pale, severely hypotensive and bradycardia (84/40 & 36) soon after the vaccine. History of egg allery as an infant. Now he is fine and eats eggs all time
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Anaemia, Influenza like illness, Laboratory test abnormal, Pancytopenia, Platelet count increased
Clinical narrative: aliterature report was receivced on 11/11/92, concerning a 60 year old female patient who experienced relapse of severe plasti anemic afterreceiving fluvirin in 11, 1998. the patient's illness was proceede by an influenza-like condition . the patient was diagnosed as having severe aplastic anemia in january,1996 when she was presenterd to the hospital with profound pancytopenia (Hb 3.9 g/dl. WBC 2.2X 10-9.L, Neutrophil count.  Follow up on 02/05/2003: "A follow up report was received from a health care professional indicating that the 6 year old female vaccinee experienced a relapse of aplastic amnesia 3 months after receiving Fluvirin on 10/14/1998.  The vaccinee was first diagnosed in 01/1996 with aplastic anaemia and want into remission in October 1998.  The vaccinee had had a previous Fluvirin vaccination on 10/20/1997.  Concomitant medication reported included cyclosporine which she had been taking due to transplant for 3 months prior to the relapse.  On 01/06/1999 the vaccinee experienced a relapse of aplastic anaemia.  The reporter indicated that the vaccinee seemed to have recovered by July 2000.  There was insufficient information to determine the reporter's causality assessment.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Eye irritation, Eye swelling, Injection site pain, Ocular hyperaemia, Urticaria
Clinical narrative: Flu vaccine given between 9-10 am. Apprx. 12 noon, RN noted pt in cafeteria c/o pain in injection area. About 1pm pt came to clinic area c/o itchy eyes, swollen red. Generalized body urticaria- no hives visible. Sent to health office
Age: 46.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Hypoaesthesia, Muscle twitching
Clinical narrative: Patient telephoned on 11/13/02 10am to describe "twitching of the right eye at 9pm on 11/12/02. At 4am on 11/13/02 he awoke with "numbness of the right side of the face." He stated that it "feels like it is full of novocaine."
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Hives
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Pain
Clinical narrative: c/o Pain in left shoulder radiating up neck. 11/12- Saw private physician who diagnosed neck sprain from ? gym equipment.
Age: 51.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Hypersensitivity, Injection site oedema, Injection site swelling, Pruritus
Clinical narrative: 1hr after receiving injection patient experience itching at site. Site was white and swelling at the size of a 50c with red circle around that. White area with edematous tissue grew larger to cover 3/4 upper arm. Took benedryl po.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Redness and swelling injection site about 4-5 cm area erythema
Age: 37.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Chills, Cough, Erythema, Myalgia
Clinical narrative: Patient developed N/V diarrhea during night after vaccine. Next morning had rigors, chills, sever pain in right arm, myalgia, headache. All symptoms continued with worsening pain, eyrethema, induration of arm (extended down einterie length of arm by 11/17), and fever to 103 despite continued NSA ID, benedryle, claritin rx. Cough developed 11/18 started on Augmentin for cough. Cellulitis. Arm simply improving by 11/18, but cough worsened, started on zithromax. Not yet recovered at time form completed.
Age: 37.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain, Pyrexia
Clinical narrative: Patient developed N/V diarrhea during night after vaccine. Next morning had rigors, chills, sever pain in right arm, myalgia, headache. All symptoms continued with worsening pain, eyrethema, induration of arm (extended down einterie length of arm by 11/17), and fever to 103 despite continued NSA ID, benedryle, claritin rx. Cough developed 11/18 started on Augmentin for cough. Cellulitis. Arm simply improving by 11/18, but cough worsened, started on zithromax. Not yet recovered at time form completed.
Age: 78.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Anorexia, Dizziness, Injection site oedema, Injection site pain
Clinical narrative: Severe pain and swelling of arm above left elbow. This lasted about 3 days. Lessened general energy, poor appetite, occassional dizziness. This lasted 5 to 6 days. Gradual returned pre- vaccination status in 7 days.
Age: 13.0
Sex: M
Vaccine: FLU3
Symptoms: Convulsion, Hypoaesthesia, Loss of consciousness, Retching
Clinical narrative: 10-15 mins after flu shot, pt in car with father and brother who report he c/o numbness in one arm, then LOC, gagging resps, Tonic/Clonic generalized movements approximately 30 secs. Pt amnesic for events.
Age: 59.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal pain upper, Chills, Injection site mass, Injection site oedema, Injection site warmth
Clinical narrative: About 30 minutes after injection, started getting sick to my stomach. By the evening, I felt real chilled and running low grade fever. My arm had a huge knot where the injection had been given. My arm swelled all around and real real hot. Temp in arm. Used cold compress arm was very painful. See my MD on 11/07/2002. Still had and still have a knot in arm. MD said a reaction to the vaccine. Arm still hurts.
Age: 59.0
Sex: F
Vaccine: UNK
Symptoms: Pyrexia
Clinical narrative: About 30 minutes after injection, started getting sick to my stomach. By the evening, I felt real chilled and running low grade fever. My arm had a huge knot where the injection had been given. My arm swelled all around and real real hot. Temp in arm. Used cold compress arm was very painful. See my MD on 11/07/2002. Still had and still have a knot in arm. MD said a reaction to the vaccine. Arm still hurts.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Contusion, Feeling abnormal, Injection site erythema, Injection site hypersensitivity, Injection site reaction
Clinical narrative: Pt c/o open sore on left arm at injection site. Pt stated it was itching this am. Pt adds he started feeling bad friday the 15th in the evening and was in bed all weekend. Pt reaction was 4 x 5 mm open sore, 10 x 10 cm in redness. CTL
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus
Clinical narrative: Pt c/o open sore on left arm at injection site. Pt stated it was itching this am. Pt adds he started feeling bad friday the 15th in the evening and was in bed all weekend. Pt reaction was 4 x 5 mm open sore, 10 x 10 cm in redness. CTL
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Hypokinesia, Injection site pain
Clinical narrative: Received pneumoccal vaccine in right deltoid 10/25/2002 about 10:30am. Apprx.  at 3:30pm ,she experienced severe pain in her right arm extending down to her fingers to the point she could not use her arm. She was taken Tylenol- Ibuprofen- applied moist heat. On 10/28/2002 when she reported it, pain had improved somewhat although she still had significant pain from her deltoid muscle to her elbow with limited use of her arm. No numbness or tingling. No bruising or redness at the sight. No fever. Gradually improved over a two week period.
Sex: F
Vaccine: FLU3
Symptoms: Injection site oedema, Injection site warmth
Clinical narrative: Phoned me at 09:37am- c/o "swollen arms, hot" denied breathing problem, denied hives, was working at Census Bureau- Nurse came in and gave flu shots on Tues. 11/12/2002.
Age: 2.0
Sex: F
Vaccine: PNC
Symptoms: Erythema, Injection site induration, Oedema
Clinical narrative: Erythema and swelling of right thigh, almost circumferenced swelling, induration noted at injection site. Erythema is patchy in pattern
Age: 80.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema, Pain
Clinical narrative: Swelling; redness, pain down arm, Benadryl PRN, Medrol dose pack, Augmentin 500mg/Bid x 1 week
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Erythema, Pain
Clinical narrative: Pneumococcal vaccine given 11/18/02, comes to office 11/20/02 with painful, reddened arm, possible cellulitis, given Augmentin 875mg BID x 10 days.
Age: 1.0
Sex: M
Vaccine: DTAP, VARCEL
Symptoms: Erythema, Oedema
Clinical narrative: Very puffy, swollen left arm. Some erythema on dorsal surface. No red streaks, no fever. Tx: Motrin. Patient's parent instructed to call if child worse. No call to date.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Back pain, Oedema peripheral, Pyrexia
Clinical narrative: 08/27/02 - Pains in right leg, Right ankle of foot swollen, RX: Motrin 08/28/02 8 pm fever 102 F, right foot and ankle worst unable  Went to hospital ER, Sed Rate=83; 08/30/02 Saw doctor, Sed Rate 09/09/02 =62, 09/23 = 50, 10/07/02 Sed  Rate =87, No med now.
Age: 9.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Injection site oedema
Clinical narrative: Swelling site of injection 72hrs after immunizations. No itching, no resp. problems.
Age: 1.0
Sex: F
Vaccine: DTAP, HIBV, IPV, MMR, PNC, VARCEL
Symptoms: Pyrexia, Urticaria
Clinical narrative: Patient broke out in hives and 102temp, "M" took child to ER. Was told reaction to one of the seven vaccines she received. Instructed to let child receive only one injection at a time to determine which vaccine she reacted to.
Age: 42.0
Sex: M
Vaccine: LYME
Symptoms: Dizziness, Fatigue, Joint stiffness, Meniere's disease, Pain
Clinical narrative: Began experiencing severe right shoulder pain in November 2000. This was followed by severe loss of range of motion and then in January 2001, by severe atrophy of right shoulder as well as numbness. Physical therapy was performed from December 200 to March 2001. This was diagnosed as axillary neuropathy of right shoulder. Pain was so severe that I had to go to a hospital emergency room 12-1-00. Shoulder has gradually regained some range of motion, strength and size, but I have been told by two neurologist that it will probably never regain all of the size, muscle mass and strength it possessed before. This has also lead to pain and stiffness in my right neck, which still persists. I began to experience pain in my right elbow in September 1999. The pain became worse in September 2001 to the point where I had to quit lifting weight for a while. The pain still persists if I lift weight or perform athletic feats such as throwing or shooting a basketball. Also I cannot entirely straighten the elbow. X-rays revealed that there is floating cartlidge and arthritis in the elbow and tendinitis also. Surgery is a possibility, but there is no guarantee it will totally solve the problem. I began to experience dizziness and resulting stomach upset in October 1999. I have since been diagnosed as having Meniere's syndrome. Dizziness became worse around November 2001 and the tinitus has became more noticeable. I see an ear, nose and throat doctor on a regular basis and take prescription medication for the problem, which fluctuates in intensity from day to day and sometimes affects my sleep when it is more intense. My right foot was already giving me discomfort starting in October 1998 due largely to a bone spur on top of the ankle. As the summer of 1999 the pain spread more to the outside of the ankle. Specialist said there is a cyst on the inside of the ankle joint, that is blocking the blood flow to the joint. An operation could be performed to open up the cyst but once again there is no guarantee it would provide noticeable benefits. I began to experience severe fatigue in September 1999. Blood work was done in October 1999 and there were no abnormalities found. Fatigue was so severe at times, I felt I could not keep my eyes open. It persisted on a regular basis until around spring 2001; since that time, it does not seem as severe, or as frequent, but it is still a problem occassionally.
Age: 42.0
Sex: M
Vaccine: LYME
Symptoms: Tinnitus
Clinical narrative: Began experiencing severe right shoulder pain in November 2000. This was followed by severe loss of range of motion and then in January 2001, by severe atrophy of right shoulder as well as numbness. Physical therapy was performed from December 200 to March 2001. This was diagnosed as axillary neuropathy of right shoulder. Pain was so severe that I had to go to a hospital emergency room 12-1-00. Shoulder has gradually regained some range of motion, strength and size, but I have been told by two neurologist that it will probably never regain all of the size, muscle mass and strength it possessed before. This has also lead to pain and stiffness in my right neck, which still persists. I began to experience pain in my right elbow in September 1999. The pain became worse in September 2001 to the point where I had to quit lifting weight for a while. The pain still persists if I lift weight or perform athletic feats such as throwing or shooting a basketball. Also I cannot entirely straighten the elbow. X-rays revealed that there is floating cartlidge and arthritis in the elbow and tendinitis also. Surgery is a possibility, but there is no guarantee it will totally solve the problem. I began to experience dizziness and resulting stomach upset in October 1999. I have since been diagnosed as having Meniere's syndrome. Dizziness became worse around November 2001 and the tinitus has became more noticeable. I see an ear, nose and throat doctor on a regular basis and take prescription medication for the problem, which fluctuates in intensity from day to day and sometimes affects my sleep when it is more intense. My right foot was already giving me discomfort starting in October 1998 due largely to a bone spur on top of the ankle. As the summer of 1999 the pain spread more to the outside of the ankle. Specialist said there is a cyst on the inside of the ankle joint, that is blocking the blood flow to the joint. An operation could be performed to open up the cyst but once again there is no guarantee it would provide noticeable benefits. I began to experience severe fatigue in September 1999. Blood work was done in October 1999 and there were no abnormalities found. Fatigue was so severe at times, I felt I could not keep my eyes open. It persisted on a regular basis until around spring 2001; since that time, it does not seem as severe, or as frequent, but it is still a problem occassionally.
Age: 10.0
Sex: M
Vaccine: HEP, HEPA, MMR
Symptoms: Rash pruritic
Clinical narrative: On Mon PM 11/11/02 child began with rash on left hand, then rash continued up arm to chest, then the rest of body-red bumps that itch. Mother has not noted any fever.
Age: 59.0
Sex: F
Vaccine: TD
Symptoms: Headache, Injection site erythema, Injection site pain, Pruritus
Clinical narrative: Received dt on11/11/02 and within a few days she developed pain redness and pruritis in the right upper arm, she also developed a frontal HA. I prescribed Benadryl 50 mg PO QID for the Pruritis . Cool compresses and recheck in two days sooner if necessary.
Age: 0.2
Sex: F
Vaccine: DTAP, HBPV, IPV
Symptoms: Dry skin, Eye oedema, Rash
Clinical narrative: c/o eye swelling and rash with dryness of skin within 24 hours of vaccine
Age: 28.0
Sex: M
Vaccine: UNK
Symptoms: Injection site erythema, Injection site mass
Clinical narrative: Lump at point of injection. Pain. ER Assessment: local nodule with redness at injection site. Supportive Care
Age: 0.75
Sex: F
Vaccine: HEP, IPV
Symptoms: Pyrexia
Clinical narrative: Received Hep B & Polio shot on 11/08/2002. Fever soon rose to increase 105 degree F. ER required.
Age: 4.25
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Left upper arem redness and swelling and tenderness x 4.5 days after vaccination.  Rx heat/ cold/ Advil
Age: 45.0
Sex: F
Vaccine: HEP
Symptoms: Chest pain, Headache, Pharyngolaryngeal pain
Clinical narrative: This report describes the occurrence of chest pain in a 45-year-old female who was vaccinated with hepatitis B vaccine recombinant (Engerix-B). This report was received from the subject and has not been verified by a physician or other health care professional. Medical history, concurrent conditions, and concurrent medications were not specified. In June 2002, the subject received her fist injection of Engerix-B. Approximately one day later, the subject experienced a headache and sore throat. The subject was seen by a physician and was treated with amoxicillin. Approximately, one month post-vaccination the, headache and sore throat persisted and the subject began to experience chest pains. Additional information was received from the subject on 08 November 2002. She stated that she presented for medical attention four separate times at three different emergency rooms. She also presented to a primary care physician for treatment. The subject stated that chest x-rays and unspecified blood analyses were "OK". The subject stated that she was too ill to work and was subsequently terminated from her job. As of 04 November 2002, she was "still sick". She stated, "I think my body has been disturbed with that shot." Because the subject reported on 08 November 2002 that she was unable to work, the events in this report are considered persistently incapacitating. Therefore, this report has been reclassified as serious, unexpected.
Age: 1.5
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Drug toxicity, Drug withdrawal syndrome, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccianted with hep B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injections of Engerix B on 7/15/97 (2293A2), 10/20/97 (2293A2), and 1/19/98 (2427A2). He also received injections of diphtheria and tetanus toxoids andpertussis vaccine (3/17/97, 5/20/97, 7/15/97 and 7/15/98). The subject's attorney alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to: a. Becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior; and b. The loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and develpmental regression in this report are considered medically serious (OMIC).
Age: 1.5
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccianted with hep B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injections of Engerix B on 7/15/97 (2293A2), 10/20/97 (2293A2), and 1/19/98 (2427A2). He also received injections of diphtheria and tetanus toxoids andpertussis vaccine (3/17/97, 5/20/97, 7/15/97 and 7/15/98). The subject's attorney alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to: a. Becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior; and b. The loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and develpmental regression in this report are considered medically serious (OMIC).
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Drug toxicity, Drug withdrawal syndrome, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hep B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injections of Engerix B on 8/30/93 (1200A2) adn 5/9/94 (1360B2). He also received injections of diphtheria and tetanus toxoids and pertussis vaccine (6/22/93 and 8/30/93), combination diphtheria and tetanus toxoids and pertussis vaccine/haemophilus influenzae type B conjugte vaccine (tetramune 10/20/94, and Haemophilus influenzae type B conjugate vacine on 6/22/93 and 8/30/93. The subject's attorney alleged that the subject "suffered devastating injuries through mercury toxicity and associted complications and sequelae and the aggravation of other condition directly through exposure, via an IM injection of mercury." The subject' attorney further alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hep B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months." The subject received injections of Engerix B on 8/30/93 (1200A2) adn 5/9/94 (1360B2). He also received injections of diphtheria and tetanus toxoids and pertussis vaccine (6/22/93 and 8/30/93), combination diphtheria and tetanus toxoids and pertussis vaccine/haemophilus influenzae type B conjugte vaccine (tetramune 10/20/94, and Haemophilus influenzae type B conjugate vacine on 6/22/93 and 8/30/93. The subject's attorney alleged that the subject "suffered devastating injuries through mercury toxicity and associted complications and sequelae and the aggravation of other condition directly through exposure, via an IM injection of mercury." The subject' attorney further alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Coma, Drug toxicity, Mental retardation severity unspecified, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a 12 month old male who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 12 months. The subject received injections of Engerix-B on 1/9/95 and 9/18/95. He also received injections of combination diphtheria and tetanus toxoids and pertussis vaccine/Haemophilus influenzae type B conjugate vaccine, diphtheria and tetanus toxoids and pertussis vaccine, and diphtheria and tetanus toxoids and acellular pertussis vaccine. The subject's attorney alleged that at approximately 12 months of age, the subject was neurologically devastated by the accumulation of Mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to  becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect. Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious.
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Social avoidant behaviour, Speech disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a 12 month old male who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 12 months. The subject received injections of Engerix-B on 1/9/95 and 9/18/95. He also received injections of combination diphtheria and tetanus toxoids and pertussis vaccine/Haemophilus influenzae type B conjugate vaccine, diphtheria and tetanus toxoids and pertussis vaccine, and diphtheria and tetanus toxoids and acellular pertussis vaccine. The subject's attorney alleged that at approximately 12 months of age, the subject was neurologically devastated by the accumulation of Mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to  becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect. Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious.
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Drug toxicity, Drug withdrawal syndrome, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 12 month old male who was vaccinated with hep B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 12 months. The subject received injections of Engerix B on 10/25/96 (2140A2) and 7/11/97 (2250A2). He also received injections of diphtheria and tetanus toxoids and pertussis vaccine 12/5/96, 1/27/97, and 3/21/97; Tripedia 4/27/98; Hib-titer 12/5/96 and 1/27/97; and influenza virus vaccine 11/2/98 and 12/9/98. The subject's attorney alleged that "At approximately 12 months of age, the subject was neurologiclly devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC). This subject's older brother experienced the same events following immunization. See report A0387134A.
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 12 month old male who was vaccinated with hep B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 12 months. The subject received injections of Engerix B on 10/25/96 (2140A2) and 7/11/97 (2250A2). He also received injections of diphtheria and tetanus toxoids and pertussis vaccine 12/5/96, 1/27/97, and 3/21/97; Tripedia 4/27/98; Hib-titer 12/5/96 and 1/27/97; and influenza virus vaccine 11/2/98 and 12/9/98. The subject's attorney alleged that "At approximately 12 months of age, the subject was neurologiclly devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC). This subject's older brother experienced the same events following immunization. See report A0387134A.
Age: 1.5
Sex: M
Vaccine: DTP, HEP, HIBV
Symptoms: Abnormal behaviour, Coma, Drug toxicity, Mental retardation severity unspecified, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months. The subject received injections of Engerix B on 11/19/98 and 2/10/00. He also received injections of diphtheria and tetanus toxoids and pertussis vaccine and Haemophilus influenzae type B conjugate vaccine. The subject's attorney alleged that the subject suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via an IM injection of mercury. The subject's attorney further alleged that at approximately 18 months of age, the subject was neurologically devastated by the accumulation of Mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect. Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious.
Age: 1.5
Sex: M
Vaccine: DTP, HEP, HIBV
Symptoms: Social avoidant behaviour, Speech disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject was allegedly born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months. The subject received injections of Engerix B on 11/19/98 and 2/10/00. He also received injections of diphtheria and tetanus toxoids and pertussis vaccine and Haemophilus influenzae type B conjugate vaccine. The subject's attorney alleged that the subject suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via an IM injection of mercury. The subject's attorney further alleged that at approximately 18 months of age, the subject was neurologically devastated by the accumulation of Mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect. Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious.
Age: 0.2
Sex: M
Vaccine: DTPHIB, HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Drug toxicity, Drug withdrawal syndrome, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hep B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and ahs not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months. The subject received injections of Engerix B on 1/18/96 (1950A2) and 2/28/96 (1965A2). He also received injections of hep B vaccine 9/20/96; Tetramune 2/28/96; diphtheria and tetanus toxoids and pertussis vaccine 4/24/96 and 8/14/96; and Hib-TITER 8/14/97. The subject's attorney alleged that the subject "suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via an IM injection of mercury." The subject's attorney further alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, havingbeen exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological developmenta previously achieved, specifically including, but not limited to: a. Becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior; and b. The loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Age: 0.2
Sex: M
Vaccine: DTPHIB, HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in an 18 month old male who was vaccinated with hep B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and ahs not been verified by a physician or other health care professional. The subject was allegedly "born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, he achieved every developmental milestone anticipated of all normally developing children until the age of 18 months. The subject received injections of Engerix B on 1/18/96 (1950A2) and 2/28/96 (1965A2). He also received injections of hep B vaccine 9/20/96; Tetramune 2/28/96; diphtheria and tetanus toxoids and pertussis vaccine 4/24/96 and 8/14/96; and Hib-TITER 8/14/97. The subject's attorney alleged that the subject "suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via an IM injection of mercury." The subject's attorney further alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, havingbeen exposed via IM vaccinations, and suddently regressed developmentally, losing milestones of neurological developmenta previously achieved, specifically including, but not limited to: a. Becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior; and b. The loss of language skills, motor skills and affect." Treatment and outcomes of these events were not specified. The mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Age: 3.0
Sex: F
Vaccine: HEPA
Symptoms: Aphasia, Speech disorder
Clinical narrative: A nurse reported the occurrence of aphasia in a 3 year old female who was vaccinated with hepatitis A vaccine inactivated for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. In October 2002, the subject received her first injection of Havrix. In the last few weeks, the subject had a pronounced change in her speech regarding the speed and fluency of her speech. She is not mute, but clearly gets frustrated when she tries to form words and now stammers. Results of computed tomography and magnetic resonance imaging were interpreted as normal. As of 11/15/02 the event persisted. The aphasia in this report is considered medically serious.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Diarrhoea, Encephalopathy, Fatigue, Mental impairment, Vomiting
Clinical narrative: Shortly after receiving vaccine, the patient was not acting like himself. Next morning, he vomited 4 times, had 2 loose stools, increased fatigue. Took to physician's office; was found to be obtunded. Transferred to ER where he had decreased mental status and was unable to protect his airway and was intubated, stabilized and transferred to PICU. Patient received 10day supply of Rocephin, 1 week of cithromax. Received FFP and cyro for discharge.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Right arm swollen redness hot to touch- vesicular pimple. Cultured site, antihistimine, antibiotic given.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: Developed cellulitis of left deltoid on 10/15/2002 and treated with Keflex snop 250/5cc  1 1/2 tsp BID x 10 day. He received IPV osu SQ and MMR # 2 osu SQ on 10/14/2002  im left tricep
Age: 26.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site mass, Injection site pain, Muscle spasms, Muscular weakness, Pain
Clinical narrative: Pt wanted to notify organization of her adverse reaction to the tetanus shot that was administered in left arm Nov. 6, 2002. That 11/6/2002 night pt experienced the normal soreness. The next day 11/07/2002 pt noticed shoulder was tender. Later on that night, pt noticed severe muscles cramps were moving across back and into right arm as well. On 11/08/2002, pt woke up in so much pain that pt could hardly dress her child. It took more time to move and pt was almost in tears when returned to clinic. They prescribed some muscle relaxers to make pain manageable. this helped for a few days. On 11/11/2002. pt returned to the office for a follow up on finger and noted to him that she was concerned that her muscles were still extremely week. During that time the noted a hard knot in my arm and some redness on my chest. On 11/14/2002, pt went back to the MD , gave pt a steroid shot and prescription to help. He stated that he did not feel that this was still a reaction to the Tetanus shot, however Pt feels that it is. He also gave me Ultracet to help ease the pain that still existed. On 11/16/2002, pt had an appointment and called to cancel. She felt that she wanted to see if pain would go with the steroids in system. The steroids did increase muscle movement and strength.  Pt indicated this to the MD office and wanted to try and wait to see if improved. 11/20/2002 finished steroid. Pt had hoped that all of the pain would be gone by now and the fact is: that is has not. 11/22/2002. pt will go get a second opinion.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Redness to left upper arm and swelling and painful. Dx Cellulitis
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site hypersensitivity, Pruritus
Clinical narrative: c/o itching 25 mins after Influenza vaccine given. Itching at left deltoid. No rash or breathing difficulty. Influenza vaccine given at 3:30pm. Benadryl 50mg po at 3:45. Vital signs checked and monitored by RN. Discharged from medical dept at 4:45pm. Ice packed applied left deltoid. Pusle Ox checked at 100 % B/P and heart rate and respiratory normal.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Injection site oedema, Injection site pain, Muscle spasms
Clinical narrative: Intial localized golf-ball sized swelling in left arm with generalized flu-like symptoms. Lingering diffuse pain and muscle spasms in left arm, shoulder, underarm area breast and pectorals. Sentfor mammogram/utrasound with negative results. I am worried and in pain. Please respond.
Age: 56.0
Sex: F
Vaccine: MMR
Symptoms: Malaise, Rash
Clinical narrative: Patient developed rash on abdomen, chest, back and face about 12 days after immunization.  Also had malaise from about two days after immunization.